James M. Mock - Oct 3, 2025 Form 4 Insider Report for Moderna, Inc. (MRNA)

Role: Chief Financial Officer
Signature: /s/ James Dillon, As Attorney-in-Fact
Stock symbol: MRNA
Transactions as of: Oct 3, 2025
Transactions value $: -$19,944
Form type: 4
Date filed: 10/6/2025, 04:23 PM
Previous filing: Aug 29, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Mock James M	Chief Financial Officer	C/O MODERNA, INC., 325 BINNEY STREET, CAMBRIDGE	/s/ James Dillon, As Attorney-in-Fact	2025-10-06	0001736359

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MRNA	Common Stock	Options Exercise		+1.45K	+8.3%		19K	Oct 3, 2025	Direct	F1
transaction	MRNA	Common Stock	Tax liability	-$19.9K	-703	-3.71%	$28.37	18.3K	Oct 3, 2025	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MRNA	Restricted Stock Units	Options Exercise	$0	-1.45K	-20%	$0.00	5.81K	Oct 3, 2025	Common Stock	1.45K		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units convert into common stock on a one-for-one basis.
F2	Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units.
F3	25% of the shares subject to this restricted stock unit award vested on October 5, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter.